ACHE and Alzheimer disease: Three out of the four approved drugs for treatment of patients with AD are ChE inhibitors: the selective reversible AChE inhibitors donepezil10 and galantamine11, and the pseudo-irreversible dual ChE inhibitor rivastigmine12 (Fig. 1a).